Thymosin β4 and angiogenesis: modes of action and therapeutic potential
- 14 July 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in Angiogenesis
- Vol. 10 (4), 229-241
- https://doi.org/10.1007/s10456-007-9077-x
Abstract
Here we review the mechanisms by which Thymosin β4 (Tβ4) regulates angiogenesis, its role in processes, such as wound healing and tumour progression and we discuss in more detail the role of Tβ4 in the cardiovascular system and significant recent findings implicating Tβ4 as a potential therapeutic agent for ischaemic heart disease.Keywords
This publication has 88 references indexed in Scilit:
- Thymosin beta 4 suppression of corneal NFκB: A potential anti-inflammatory pathwayExperimental Eye Research, 2007
- Zyxin is upregulated in the nucleus by thymosin β4 in SiHa cellsExperimental Cell Research, 2006
- Gene Expression Analysis of Zebrafish Heart RegenerationPLoS Biology, 2006
- Prolyl Oligopeptidase Is Involved in Release of the Antifibrotic Peptide Ac-SDKPHypertension, 2004
- Expression of thymosin beta4 during chick developmentBrain Structure and Function, 2004
- The angiopoietins and Tie2/Tek: adding to the complexity of cardiovascular developmentSeminars in Cell & Developmental Biology, 2002
- Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularizationJCI Insight, 1999
- A novel β-thymosin from the sea urchin: extending the phylogenetic distribution of β-thymosins from mammals to echinodermsJournal of Peptide Science, 1997
- Thymosin β10 mRNA expression during early postimplantation mouse developmentFEBS Letters, 1996
- Thymosin β-4 Expression Is Correlated with Metastatic Capacity of Colorectal CarcinomasBiochemical and Biophysical Research Communications, 1993